MedTrace Logo

GUIDOR® Growth Factor Enhanced Bone Graft Substitute for the Treatment of Periodontal Defects 6-months Post-Surgery

NCT01728844 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 88

Last updated 2020-09-17

Study results available
· View outcomes & findings →

Summary

GUIDOR Growth Factor Enchanted Bone Graft Substitute (GFeBGS) when used in periodontal surgery will shown greater gum and bone regeneration when compare to bone graft substitute alone. Also, to find the optimal dose.

Conditions

  • Alveolar Bone Loss
  • Periodontal Diseases

Interventions

DEVICE

beta-tricalcium phosphate alone

DEVICE

GFeBGS 0.1%

DEVICE

GFeBGS 0.3%

DEVICE

GFeBGS 0.4%

Sponsors & Collaborators

  • Sunstar Americas

    lead INDUSTRY

Principal Investigators

  • David L. Cochran, DDS, PhD · University of Texas Health Sciences Center at San Antonio

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
25 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2012-10-31
Primary Completion
2014-08-31
Completion
2014-08-31

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01728844 on ClinicalTrials.gov